Compare WWR & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WWR | ONMD |
|---|---|---|
| Founded | 1977 | 2006 |
| Country | United States | United States |
| Employees | N/A | 23 |
| Industry | Metal Mining | |
| Sector | Basic Materials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.3M | 56.0M |
| IPO Year | 2006 | N/A |
| Metric | WWR | ONMD |
|---|---|---|
| Price | $0.57 | $0.91 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.92 | N/A |
| AVG Volume (30 Days) | ★ 946.8K | 857.0K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.46 | $0.31 |
| 52 Week High | $3.75 | $4.22 |
| Indicator | WWR | ONMD |
|---|---|---|
| Relative Strength Index (RSI) | 36.36 | 49.91 |
| Support Level | N/A | $0.92 |
| Resistance Level | $0.72 | $0.97 |
| Average True Range (ATR) | 0.03 | 0.08 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 16.96 | 48.84 |
Westwater Resources Inc is an energy technology company focused on developing battery-grade natural graphite materials through a vertically integrated, mine-to-market strategy anchored by its two primary projects in Coosa County, Alabama: the Kellyton Graphite Plant and the Coosa Graphite Deposit. Westwater also holds mineral rights to explore and mine the Coosa Graphite Deposit, which Westwater anticipates will eventually provide natural graphite flake concentrate as feedstock to the Kellyton Graphite Plant.
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.